Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 13Gastrointestinal 7Thoracic 6Other hematologic neoplasm 3Myeloid 3Sarcoma 2Lymphoid 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Melanoma 467Skin Neoplasms 144Carcinoma, Basal Cell 94Breast Neoplasms 78Neoplasms 68Lymphoma, T-Cell, Cutaneous 62Lung Neoplasms 57Carcinoma, Squamous Cell 40Carcinoma, Non-Small-Cell Lung 40Mycosis Fungoides 39Uveal Melanoma 38Sezary Syndrome 37Lymphoma, Non-Hodgkin 35Lymphoma 35Keratosis, Actinic 35Pancreatic Neoplasms 34Sarcoma 33Prostatic Neoplasms 33Head and Neck Neoplasms 33Colorectal Neoplasms 33Leukemia, Lymphocytic, Chronic, B-Cell 31Ovarian Neoplasms 30Urinary Bladder Neoplasms 29Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Colonic Neoplasms 28Lymphoma, Mantle-Cell 27Lymphoma, Follicular 27Leukemia 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Dermatologic × Clear all
NCT00342797 2024-03-07

Retinoblastoma Biomarker Study

National Institutes of Health Clinical Center (CC)

Completed
2,136 enrolled
DermatologicOther solid neoplasmSarcoma

Melanoma, Retinoblastoma, Sarcoma, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡